Adagene Inc ADR (ADAG) Stock Price, Quote & News

SuperGreenToday Dec. 24 at 2:49 PM

0 · Reply

justiceforb_85 Dec. 17 at 11:08 PM

$ADAG decided to add. Muzastotug with promising data and likely best-in-class. Possible BO candidate given $MRK partnership.

0 · Reply

ZacksResearch Dec. 17 at 2:24 PM

$ADAG rips higher — FDA Fast Track just lit the fuse 🚀 Adagene jumped 13.8% after the FDA granted Fast Track Status to muzastotug in combination with pembrolizumab for MSS metastatic colorectal cancer, putting this program on an accelerated regulatory path. Full catalyst breakdown here 👉 https://www.zacks.com/stock/news/2805441/fda-grants-fast-track-designation-to-adags-colorectal-cancer-drug?cid=sm-stocktwits-2-2805441-teaser-25131&ADID=SYND_STOCKTWITS_TWEET_2_2805441_TEASER_25131

0 · Reply

ZacksResearch Dec. 17 at 1:24 PM

Fast Track boost for $ADAG — but is it enough? 🚀 FDA granted Fast Track to muzastotug with Keytruda for MSS mCRC without current or active liver metastases, sparking a 13.8% share surge. Yet, ADAG's shares are down 6.9% over the past year, trailing the industry's 16.3% rise. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2805441/fda-grants-fast-track-designation-to-adags-colorectal-cancer-drug?cid=sm-stocktwits-2-2805441-body-25129&ADID=SYND_STOCKTWITS_TWEET_2_2805441_BODY_25129

0 · Reply

justiceforb_85 Dec. 17 at 3:13 AM

$ADAG wondering how muzastotug compares to botensilimab by $AGEN which is further along in development?

1 · Reply

stevenryl86 Dec. 17 at 2:05 AM

$ADAG I dig further, ADG126 interim data in early 2026 should highlight for potential buyout.

1 · Reply

Streax Dec. 16 at 9:26 PM

$ADAG whats the chances $MRK buys out $ADAG? Is there value there or not worth the headache?

0 · Reply

stevenryl86 Dec. 16 at 9:13 PM

$ADAG drop the pr or 8k please?

0 · Reply

BioTuesdays Dec. 16 at 5:09 PM

$ADAG has announced that the FDA has designated muzastotug, in combination with Merck’s (NYSE: MRK) anti-PD-1 therapy, KEYTRUDA (pembrolizumab), as a fast track product for adult patients with microsatellite stable metastatic colorectal cancer (MSS mCRC) without current or active liver metastases https://biotuesdays.com/2025/12/16/fda-grants-fast-track-designation-for-adagenes-muzastotug/

0 · Reply

Streax Dec. 16 at 3:40 PM

$ADAG good news no volume!

0 · Reply

AStrokeOfLuck Dec. 16 at 2:26 PM

$ADAG $PVLA

0 · Reply

Streax Dec. 16 at 2:02 PM

$ADAG $SPY $BCRX $SLS

0 · Reply

JohnTrack Dec. 16 at 1:43 PM

$ADAG checking vibes on this one!

0 · Reply

OpenOutcrier Dec. 16 at 1:32 PM

$ADAG (+11.4% pre) Adagene stock soars after FDA grants Fast Track status for cancer therapy https://ooc.bz/l/87602

0 · Reply

Simple_Math Dec. 16 at 1:18 PM

$ADAG, $AMCI, $VERO, $RILY

0 · Reply

topstockalerts Dec. 16 at 1:01 PM

Pre Market Top Gainers PT2 $RILYZ $CLPT $QURE $ADAG $VRA

0 · Reply

notreload_ai Dec. 16 at 12:55 PM

$ADAG receives FDA Fast Track designation for muzastotug, a novel cancer therapy targeting hard-to-treat colorectal cancer patients. https://notreload.xyz/adagene-cancer-treatment-gets-fda-fast-track-status/

0 · Reply

Stock_Catcher Dec. 16 at 12:48 PM

$ADAG thin

0 · Reply

chillyv1 Dec. 16 at 12:24 PM

$ADAG https://www.stocktitan.net/news/ADAG/adagene-announces-fda-fast-track-designation-for-muzastotug-gnr2ppam0q7d.html

0 · Reply

Ididize Dec. 16 at 12:11 PM

$ADAG Fast track Cancer $ASNS $VERO

0 · Reply

stevenryl86 Dec. 16 at 12:05 PM

$ADAG FDA Fast Track, load up!

0 · Reply

JohnTrack Dec. 16 at 12:05 PM

$ADAG Fast track hype!! https://www.rapidticker.com/news/adag-adagene-announces-fda-fast-track-959537

0 · Reply

Market Cap	87.19M
Revenue (ttm)	100,000.00
Net Income (ttm)	-33.42M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-33,420.00%
Debt to Equity Ratio	0.12

Volume	14,600
Avg Vol	135,784
Day's Range	N/A - N/A
Shares Out	47.13M
Stochastic %K	53%
Beta	0.71
Analysts	Strong Sell
Price Target	$6.90

Adagene Inc ADR (ADAG)

Company Profile